Presentation

---

May 2022- Adenosine-Pathway Targeted Cancer Immunotherapy Summit

【BP1200,BP1202】 Targeted Inhibition of Adenosine Pathway by Humanized Antibodies to Enhance the Cancer Immunity

April 2022- AACR 2022

【BP2301】 Development of piggyBac transposon mediated HER2-CAR-T cells for the treatment of solid tumors [PDF 9.0MB]

【BP1200】 A novel anti-CD73 therapeutic antibody that ameliorates the tumor microenvironment and improves the efficacy of cancer immunotherapy [PDF 4.5MB]

【BP1209】 Personalized neoantigen cancer vaccine assembled on DC targeting antibody improves cancer immunity [PDF 2.3MB]

【BP1209】 A novel computational pipeline supported with in vivo T cell induction data for identification and validation of neoantigens [PDF 1.3MB]

January 2022- Cancer Science(publication)

【BP1209】 Development of antigen-prediction algorithm for personalized neoantigen vaccine using human leukocyte antigen transgenic mouse
Cancer Science 2022 Apr;113(4):1113-1124. [PDF 10.9MB]

November 2021- SITC 2021

【BP1210】 Novel biparatopic TIM-3 antibody effectively blocks multiple inherent ligands and activates anti-tumor immunity [PDF 1.1MB]

September 2021- ESMO 2021

【BP1200】 A novel therapeutic antibody against CD73 that ameliorates the tumor microenvironment and improves the efficacy of cancer immunotherapy [PDF 4.5MB]

【BP1209】 A new platform of personalized neoantigen cancer vaccines directed by checkpoint inhibitor antibodies to improve cancer immunity [PDF 5.6MB]